Explore tweets tagged as #Bioshield
My meeting with @POTUS and HRH MBS in May 2025 resulted in such amazing results and action! In less than a year we received the world’s first approval for lung cancer for the Bioshield… and now we have established a wholly owned subsidiary in the Kingdom to support physicians
112
769
4K
It started with a handshake in Riyadh. May 2025. Two world leaders. One mission: bring immunotherapy to mankind and cure cancer. Less than a year later — EU authorization across 33 countries. The world's first lung cancer approval of the Bioshield in Saudi. Distribution
ImmunityBio is forging new ground in the Middle East with a regional office in Saudi Arabia and a commercial partnership with Biopharma Cigalah. This initiative supports clinicians and health systems throughout the Middle East and North Africa, furthering our mission to extend
38
167
848
President Trump and HRH MBS : a shared vision to cure cancer with the BioShield. America’s innovation and sharing with the world as a policy for world peace. Saudi FDA rapid approval !! Now they lead the way.
"Healthcare as a foreign policy for world peace:" Watch Dr. Patrick Soon-Shiong discuss the historic USA-Saudi Biotech Alliance and the shared vision to transform global cancer care. #GlobalHealth #Biotech #Diplomacy #CancerResearch
55
173
815
Excited to launch chemotherapy free lymphodepletion free Bioshield especially in Waldenstrom lymphoma with now 15 month durable CR. To date 5 patients with Waldenstrom enrolled. Interested patients with Waldenstrom’s should contact
At ImmunityBio, our pipeline continues to expand with chemotherapy-free approaches designed to harness the power of one's own immune system. We have launched ResQ215B, a Phase 2 clinical study evaluating a novel chemotherapy-free and lymphodepletion-free combination
30
154
755
Thanks I know this sounds crazy but I wrote hundreds of words on X on the ARTICLES section of X to connect the dots. It’s there for anyone to read still ..the world is finally waking up to this diagram ..the Bioshield platform executed across multiple clinical trials..
@DrPatrick @joeroganhq He’s been telling us for years, but no one would listen! Dr. PSS is unleashing the immune system to fight cancer and infectious disease! Unstoppable!!!!@joerogan
41
223
1K
Looking forward to finally deconstructing this mind map of the path to winning the war against cancer and harnessing the power within. I realize that this diagram which appeared simple requires careful deconstruction and explanation to understand the implementation of BioShield
44
109
770
Good beginning of the year of the fire horse. Detailed press release laying out the 3 year expansion plan of the Bioshield platform tomorrow ..stay tuned @ImmunityBio
47
108
1K
2026 is a decade since I filed this patent on June 2016. The NANT Cancer Vaccine (The Cancer BioShield Platform) is now in full scale development at @ImmunityBio. Finally, the drive to memory NK and T cells for long-term survival is being proven. This figure is another
84
266
2K
Dr. Patrick Soon-Shiong (@DrPatrick) announced that Saudi Arabia is eager to expand #ANKTIVA & the Cancer BioShield platform to many other types of cancer. The UAE is now actively considering it as well. He hopes the current U.S. administration won’t waste any more time & will
22
113
502
$IBRX Speculation: The speculation around $IBRX and #VeraRubin is getting loud. 📈 Whether the 4,500 chip rumor is spot on or just early, the logic holds: You don't build a Cancer BioShield'in 2026 without massive compute. 🧬 If ImmunityBio is moving toward $NVDA's agentic
1
4
53
$IBRX Imagine taking ANKTIVA as a prophylactic? I mean, given our nutrition from food has diminished over the last century, so went our immune systems. The #Bioshield platform could be our helping hand in fighting disease and cancers. Aren’t you excited for the future?
2
13
103
This month: Exciting 2nd summit w Dr. Soon-Shiong at Saudi Biotech Alliance in the capital, Riyadh. Agenda: 1. Sharing combinations of Anktiva & NK-cell therapy (AKA Bioshield) w oncology leaders. Agenda: 2. Sharing results of Soon-Shiong's clinical trials on breast, lung,
The 2nd USA: Saudi Biotech Alliance summit to be held this month in Rhiyadh - this time a sharing of all the combinations of Anktiva and NK cell therapy with oncology thought leaders and leadership in Saudi and setting the launch of Anktiva with NKcell therapy- immunotherapy 2.0
0
6
39
$IBRX @DrPatrick announced that Saudi Arabia is interested in expanding ANKTIVA & BioShield cure to many other type of cancers while UAE is now considering it as well. He hopes current US Admin won’t waste more time and follow suit.
16
88
478
The $1T Thesis for $IBRX: •Sovereign Scaling: Saudi Arabia’s SFDA approvaland the MISA partnership transform IBRX from a biotech into a national security asset. Localized manufacturing in the Kingdom creates a Middle Eastern hub for the Cancer BioShield. •European Rollout:
0
9
91
$IBRX we already have it here in USA, it is called Bioshield powered by ANKTIVA but, the chemo/ radiation industry BigPharma is blocking it via @US_FDA
🚨 Single vaccine could shake the global cancer industry to its core China is preparing to approve Russia’s groundbreaking cancer vaccine, a development that could disrupt the $2.6 trillion Western oncology market. This vaccine, designed to target and train the immune system to
4
18
116
$IBRX- IBRX UPDATE: THE "BIOSHIELD" IS OFFICIAL The ASCO GU 2026 abstracts officially dropped at 5:00 PM ET today. For those seeing "0 results" on the search bar: This is a standard site indexing lag. The data is public and the embargo is LIFTED. The Clinical "Audit" (36-Month
3
11
85
Last year, Rockefeller researchers reported that ~60% of people who received N-803 (Anktiva, aka BioShield) + 2 bnAbs had delayed HIV rebound for at least 24 wks after stopping antiretrovirals. But data presented tis year at #CROI2026 weren't so promising... 1/
Anktiva—the BioShield for HIV—published today! Prof. Caskey (Rockefeller Univ): “What we’re most excited about is… some participants maintain low-level viremia for a prolonged time.” Next up: Long COVID trials. NK cells matter. Clear the virus! #HIV
https://t.co/iiETIQ7eEi
3
4
8
@LsFaith @JDVance I haven't seen @DrPatrick offer ANKTIVA yet, that's what Scott Adams took shortly before he rapidly deteriorated and died. Bioshield ANKTIVA $IBRX
4
3
44
If you're new to $IBRX you're likely going to stumble upon Anktiva and think you have found a company with one miracle-drug, which would be fair. However, it's much bigger than that. It's better to view $IBRX as highly vertically integrated company developing a BioShield. Think
7
49
251